BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 19, 2020
View Archived Issues
Thanks for the memories, myelin
Read More
Nanogold improves MS symptoms
Read More
European Commission approves Vyndaqel for ATTR-CM
Read More
FDA approves Procysbi delayed-release oral granules in packets
Read More
PT-112 shows promising activity in mCRPC both as monotherapy and in combination with avelumab
Read More
AABH as new predictive biomarker for early diagnosis of prostate cancer
Read More
ATLAS study of rucaparib in mUC suspended due to lack of activity
Read More
Jiangsu Chia Tai Tianqing Pharmaceutical and collaborators patent BRD4 inhibitors
Read More
New IDO-1 inhibitors identified at Bristol-Myers Squibb
Read More
City of Hope National Medical Center discovers PARG inhibitors
Read More
NZP UK, University of Southampton identify FXR agonists
Read More
Toll-like receptor 7/8 antagonists identified at Merck KGaA
Read More
Improvements seen with olipudase alfa in pediatric patients with acid sphingomyelinase deficiency
Read More
Bipolar-like behavior key factor found in iPSCs and mice
Read More
miR-27a-3p is a potential therapeutic target in prostate cancer
Read More
Novel microglia-specific reporter mouse model based on the TMEM119 microglia marker
Read More
Combination of new CD28- and CD3-based bispecific antibodies shows high antitumor activity
Read More
CD229-specific CAR T cells with strong activity against multiple myeloma in vitro and in vivo
Read More
Axim advances pharmacokinetic study of cannabinoid-based chewing gum with dronabinol
Read More
Complete response recorded in first patient treated with optimized MB-106 in phase I/II study
Read More
Diasome reports promising outcomes from phase II trial of HDV added to insulin in type 1 diabetes
Read More
Zelira's phase Ib/IIa study of ZLT-101 in insomnia meets primary endpoints
Read More
Phase II trial of cabiralizumab with nivolumab in advanced pancreatic cancer misses primary endpoint
Read More